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WOMEN'S HEALTH

PMS and Eosinophilia-myalgia syndrome
Mary E. Guinan, MD, PhD
In
November
1989, the Centers
for Disease Control reported a
cluster of cases of
the newly emerging Eosinophiliam y a I g i a s y ndrome. 1•2 First reported from New
Mexico and associated with the ingestion of the amino acid L-tryptophan, the number of reported cases
has increased to more than 1,000 as of
January 1990; they come from every
state but Alaska and 84% ofcases are
in women!
The majority of sufferers have reported arthralgias, cough, shortness
of breath, fever, and edema ofthe extremities. Periorbital edema, scleridermiform skin changes, alopecia, and
neuropathy or neuritis occurred in
approximately 20% of cases. Eosinophil counts ranged from 1,000 to
65,000 cellsjmm3• Pleural effusions
and pulmonary infiltrates were found
in 10% of patients who had chest
X-rays. Thirty-six percent of patients
were hospitalized and seven deaths
have been reported, only one of which
has been confirmed as directly attributable to the syndrome.
Virtually all patients had ingested
L-tryptophan before onset of symptoms. L-tryptophan is marketed as a
food supplement in grocery stores and
health food establishments as well as
drug stores. Despite lack of sound evidence, it has been advocated as a
treatment for premenstrual syndrome
(PMS) and insomnia. The PMS connection may explain the preponderance of cases in women. L-tryptophan
has been touted as a natural antidepressant and hypnotic. So-called natural treatments are very appealing to
a large proportion of the population,
especially in this health conscious era.
For women who suffer from PMS, I
imagine that it is particularly appeal60
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ing because of the lack of a universally accepted treatment for PMS.
Many different PMS treatments
have been advocated, including high
doses of specific or multiple vitamins,
but nothing has been shown effective
when studied in appropriate controlled trials. Herein lies the dilemma:
What can we do for patients suffering
from PMS? Our obligation as physicians is first, to do no harm, but also
to minister to our patients' needs.
When we recommend unproven treatments or regimens for PMS that appear to be benign (ie, have no or minimal side effects) we hope to fulfill
both these mandates. We need to follow our patients to determine how effective the treatment is and to ensure
that no serious side effects occur.
Therapy would be discontinued if either the patient saw no improvement
or if suspected side effects developed.
What happens when the so-called
natural remedies like herbs, food supplements, vitamins, or minerals are
advocated by various business establishments? Large chain drug stores,
health food establishments, or supermarkets can make huge profits from
selling these "natural" remedies for
PMS. No provision is made for evaluation or followup for adverse effects.
I am always surprised by women who
have a healthy skepticism for both
physicians and prescribed medications, but who uncritically embrace
natural remedies advocated by commercial interests with clear profit motives. Perhaps it is the word "natural"
that is appealing and denotes safety to
many consumers.
L-tryptophan is an amino acid naturally occurring in many foods. No
one knows how widely used it is or
what constitutes the average dose. In
an analysis of some 400 cases of the
Eosinophilia-myalgia syndrome, dosages ranged from 26 mg to 18,000 mg
per day with a median dosage of 1,500
mg per day. Many of those affected
did not relate their symptoms to the

L-tryptophan and kept consuming
ever larger doses until they became
incapacitated and were hospitalized.
Before the epidemic was recognized,
many patients did not report the use
of the amino acid when describing
symptoms because they didn't consider it a medication. When patients
were contacted after the association
was made, all stated they had used Ltryptophan and some were still using
it.
Whether it is the L-tryptophan itself or some contaminant in the manufacturing process that causes the
symptoms is unknown. The symptoms
closely resemble toxic oil syndrome, 2
which occurred in epidemic form in
Spain in 1981. In that outbreak, the
ingredient or contaminant in the cooking oil that caused the symptoms was
never established. A link between Ltryptophan and the cooking oil is now
being investigated. The Food and
Drug Administration has issued anationwide recall of all L-tryptophan
and L-tryptophan containing products.
I wish I could come up with some
moral to this tale. What I can do is to
alert physicians to the association of
L-tryptophan and this new syndrome
and to suggest that we ask all our patients about natural remedies as well
as medications they may be taking.
For women with PMS, I advise caution in what you take whether prescribed by a physician or your local
grocer.
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